MRX-800 (maralixibat)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRX-800 (maralixibat), covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study [Phase 2]